CD8A and myelodysplastic syndrome: We further engaged scRNA-seq to assess the transcriptional profile of BM-sorted CD8+ T cells from patients with MDS and secondary AML at the highest possible resolution, to identify molecular signatures in specific CD8+ T subpopulations tied to favorable outcomes [163].